Grigoris Gerotziafas: The Evolving Landscape of Genetic Risk Assessment in VTE
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of the CRSA at Sorbonne University, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Polish Archives of Internal Medicine, adding:
”The VAS Group is pleased to announce the publication of our latest review article in the Polish Archives of Internal Medicine (PAIM):
‘Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction’
This is an updated overview of the evolving landscape of genetic risk assessment in venous thromboembolism (VTE), moving from conventional inherited thrombophilia testing toward next-generation genomic and polygenic risk prediction approaches.
Key messages of the review include:
- The complex interaction between genetic, acquired, and environmental determinants of VTE
- The current and future role of classical thrombophilia testing (Factor V Leiden, Prothrombin G20210A, antithrombin, protein C and protein S deficiencies)
- The emergence of genome-wide association studies (GWAS)-derived polygenic risk scores as innovative tools for individualized VTE risk stratification
- The potential integration of genomic medicine into precision thrombosis prevention and management
- The major scientific and clinical barriers that still limit implementation in routine clinical practice
This publication highlights the growing importance of precision medicine and translational vascular science in the management of thrombotic disease.
Congratulations and sincere thanks to all co-authors and collaborators for this excellent international collaborative work.”
Title: Inherited thrombophilia and polygenic risk scores in venous thromboembolism: from classical testing to genomic risk prediction
Authors: Benilde Cosmi, Grigoris Gerotziafas, Peter Marschang, Matija Kozak, Mariella Catalano, Agata Stanek
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters